Early brain injury (EBI) following subarachnoid hemorrhage (SAH) is an important cause of high mortality and poor prognosis in SAH. B-cell lymphoma 2-associated X protein inhibitor-1 (BI-1) is an evolutionarily conserved antiapoptotic protein that is primarily located in the membranes of endoplasmic reticulum (ER). BI-1 has been studied in certain nervous system-associated diseases, but the role of this protein in SAH remains unclear. In the present study, the role of BI-1 in EBI following SAH was investigated in rat models and its associated mechanisms were examined. The SAH rat model was generated by inserting nylon cords into the internal carotid artery from the external carotid artery. Samples were assessed using neurological scores, brain water content measurements, hematoxylin and eosin (H&E) staining, blood-brain barrier (BBB) permeability, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling and quantitative polymerase chain reaction assays, and western blot analyses. It was identified that the mRNA and protein levels of BI-1 decreased markedly and were lowest at 24 h after SAH. BI-1 overexpression and small hairpin RNA (shRNA)-mediated silencing markedly suppressed or severely exacerbated EBI following SAH, respectively. BI-1 overexpression in the SAH model improved neurological scores and decreased the brain water content, BBB permeability and levels of apoptosis compared with the control and sham groups following SAH. BI-1 shRNA in the SAH model demonstrated contrary results. In addition, the mRNA or protein expression levels of ER stress-associated genes (glucose regulated protein, 78 kda, c/EBP homologous protein, Serine/threonine-protein kinase/endoribonuclease IRE1, c-Jun N terminal kinases and apoptotic signaling kinase-1) were markedly suppressed or increased following BI-1 overexpression and shRNA-mediated silencing, respectively. The present study suggested that BI-1 serves a neuroprotective role in EBI following SAH by attenuating BBB disruption, brain edema and apoptosis mediated by ER stress.
Introduction
Subarachnoid hemorrhage (SAH) is one of the most common cerebrovascular events, with high rates of mortality and disability (1) . SAH may occur at different ages, ranging from children to the elderly, and the incidence gradually increases with age. Although drugs and surgical technologies are being continuously developed, the mortality rate remains as high as 30-50%, and the prognosis of patients with SAH is poor (1) .
Early brain injury (EBI) refers to direct injury to the whole brain within the initial 72 h after SAH. EBI is a complicated event that is the result of normal brain physiological disorder, which may lead to early brain edema, oxidative stress, apoptosis and cerebral infarction, and may subsequently lead to mortality or severe disability (2, 3) . The term EBI has been adopted and describes an immediate injury to the brain following SAH prior to the onset of delayed vasospasm (4) . during the EBI period, a ruptured aneurysm causes a number Bax inhibitor-1 suppresses early brain injury following experimental subarachnoid hemorrhage in rats of physiological disruptions, including increased intracranial pressure (IcP), decreased cerebral blood flow (cBF), and global cerebral ischemia. These events initiate secondary injuries including blood-brain barrier disruption, inflammation and oxidative cascades that all ultimately lead to cell death (4) . Therefore, studies on EBI have substantial potential value in the treatment and prognosis of patients with SAH. At present, a number of studies have identified that early brain injury may be a primary factor of poor prognosis of SAH (2, 3, 5) . SAH may lead to neuronal cell apoptosis, and apoptosis primarily occurs in neurons of the hippocampus and basal cortex (6, 7) . SAH also disrupts the blood-brain barrier (BBB) and increases permeability (4, 5) . cerebral edema is a direct result of BBB destruction. It has been suggested that a number of signal pathways serve important roles in EBI following SAH. The phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, a key antiapoptotic signaling pathway associated with EBI following SAH (8) (9) (10) , and the c-Jun N-terminal kinase (JNK) associated signal pathway have been studied in EBI (7) . B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax) inhibitor-1 (BI-1), also known as TMBIM6, was first identified by exploiting the lethal phenotype of Bax in yeast (11) . BI-1 is an evolutionarily conserved endoplasmic reticulum (ER) protein that suppresses cell death in animal and plant cells (12) . Numerous studies have suggested a role of ER stress in neuronal cell death (13, 14) .
BI-1 has an association with ER, and it may also suppress the apoptosis induced by Bax. It has been demonstrated that ER is involved in the apoptosis induced by unfolded protein responses (UPRs) (15) . Among the UPRs, inositol-requiring enzymes (IRE) are associated with cell death (14) . Serine/threonine-protein kinase/endoribonuclease IRE1 (IRE1) is an important factor in the ER-targeted activities of Bcl-2-family proteins (16) . Glucose regulated protein, 78 kda (GRP78) may regulate ER function during ER stress (17) . IRE1 may activate downstream protein kinases, particularly apoptotic signaling kinase-1 (ASK1), which may cause JNK activation (18) . IRE may also activate p38 mitogen activated protein kinase (MAPK), which activates the transcriptional regulator c/EBP homologous protein (cHOP) that controls the expression of numerous apoptotic genes (19) . The cytoprotective activity of BI-1 is closely associated with ER stress (20, 21) .
The function of BI-1 has been studied in a number of pathological models, including non-small cell lung cancer (22) , prostate cancer (23), liver regeneration (24), ischemia (21) and diabetes (25) . It has been demonstrated that BI-1 protects against stroke and traumatic brain injury (20) . Bax inhibitor-1 may improve survival and neuronal differentiation of embryonic stem cells via the differential regulation of MAPK activities (26) . BI-1 overexpression in the ER is protective in neurons (27) . It has been suggested that the expression of BI-1 may be regarded as a novel therapy for brain-associated diseases. However, studies concerning the association between BI-1 and SAH have rarely been performed.
The present study investigated whether BI-1 protected the brain against EBI following SAH in rats. In addition, the role of ER stress-mediated apoptosis in SAH rat models was discussed.
Materials and methods
Ethics statement and animals. Seventy healthy male Sprague-dawley rats (7-week old), weighing 180-200 g, were purchased from the Experimental Animal center of Kunming Medical University (certificate no. SCXK2005-0008). The animal experiments were approved by the Animals Ethics committee of Kunming Medical University and the Guide for the care and Use of Laboratory Animals. All rats were housed in a humidity-controlled (50-65%) pathogen-free environment with ad libitum access to food and water under 12/12 h light: Dark cycle (18-22˚C).
Plasmids. The rat BI-1 sequence was obtained from NcBI (https://www.ncbi.nlm.nih.gov/nuccore/NM_019381.2), and inserted into the pcdH plasmid (System Biosciences, LLc, Palo Alto, cA, USA) with EcoRI and NotI enzyme sites. The short hairpin RNA (shRNA) sequence for BI-1 was 5'-GcA ccT AAA GAA GGT cTA TGc-3' (Sangon Biotech co., Ltd., Shanghai, china). The BI-1 oligos (forward, 5'-ccG GGc Acc TAA AGA AGG TcT ATG ccT cGA GGc ATA GAc cTT cTT TAG GTG cTT TTT G-3' and reverse, 5'-AAT TcA AAA AGc Acc TAA AGA AGG TcT ATG ccT cGA GGc ATA GAc cTT cTT TAG GTG c-3') (Sangon Biotech co., Ltd.) were annealed and inserted into the pLKO.1 plasmid (Addgene, Inc., cambridge, MA, USA) with EcoRI and AgeI enzyme sites. The shRNA sequence for scrambled shRNA/pLKO.1 (Addgene, Inc.) was 5'-ccT AAG GTT AAG TcG ccc TcG-3'. These plasmids were sequenced by Sangon Biotech co., Ltd. Furthermore, the efficiency of plasmids was verified by quantitative polymerase chain reaction (qPcR) and western blot analysis according to the following protocol. The sequence of rat BI-1 as follows: 5'-ATG AAT ATA TTT GAT cGG AAG ATc AAc TTT GAT Gcc cTc TTA AAA TTT Tcc cAc ATA AcT ccc Tcc AcA cAG cAG cAc cTA AAG AAG GTc TAT Gcc AGT TTT GcA cTG TGc ATG TTT GTG GcA GcA GcA GGG Gcc TAT GTc cAT GTG GTc AcA cGT TTc ATc cAG GcT GGc cTG cTc TcT Gcc cTG GGc Gcc cTG Gcc TTG ATG ATT TGc cTG ATG Gcc AcA ccT cAc AGc cAT GAG AcG GAG cAG AAG AGG cTG GGA cTG cTc GcT GGc TTc Gcc TTc cTT AcA GGA GTT GGc cTG GGA ccT Gcc cTG GAG cTG TGc ATT Gcc ATc AAc ccc AGc ATc cTc ccc AcG Gcc TTc ATG GGc AcG Gcc ATG ATc TTc Acc TGc TTc AGc cTG AGT Gcc cTc TAc Gcc AGG cGc cGG AGT TAc cTc TTT TTG GGA GGT ATc TTG ATG TcA Gcc ATG AGc cTc ATG TTc GTG Tcc TcT cTG GGG AAc cTT TTc TTT GGA Tcc ATT TGG cTG TTc cAG GcA AAc cTG TAc ATG GGG cTG cTG GTc ATG TGc GGc TTT GTc cTc TTc GAc AcT cAG cTc ATT ATT GAA AAG GcT GAA cAc GGA GAc AAG GAT TAc ATc TGG cAc TGc ATT GAc cTc TTc TTG GAc TTc GTT AcA cTc TTc AGG AAG cTc ATG cTG ATc TTG Gcc TTc AAT GAG AA GGA cAA AAA GAA AGA GAA GAA GTG A-3'.
Transfection. The following groups were designed: Nc group (transfection reagent), pcdH group, BI-1/pcdH, BI-1/pLKO.1 shRNA and scrambled shRNA/pLKO.1. The aforementioned plasmids were transfected with Lipo8000™ Transfection Reagent (Beyotime Institute of Biotechnology, Haimen, china) into rat normal neuron cells (Chi Scientific, Inc., Maynard, MA, china), respectively. A total of 48 h after transfection, all transfected cells were collected for qPcR and western blot analysis, according to the following protocol.
SAH model and transfection. The rats were randomly divided into the following five groups (n=8): control; sham; SAH 24 h; SAH 48 h; and SAH 72 h groups. The SAH model was induced in rats via puncture of the internal carotid artery. The SAH rat model was generated according to a protocol outlined by Prunell et al (28) . Briefly, the rats were anesthetized with sodium pentobarbital [30 mg/kg body weight, intraperitoneal injection (i.p)]. Then, the right carotid artery branch was exposed, and the external carotid artery (EcA) was blocked by vascular clamp. The EcA was cut at the proximal end of the vascular clamp, a nylon cord was inserted into the internal carotid artery from the EcA and then moved forward 3 mm when resistance was felt. Subsequently, the nylon cord was quickly removed. In total, the entire procedure lasted <30 sec. The rats in the sham group only had the right carotid artery branch exposed, without any surgery, and rats in the control group had not undergone any surgical procedures. Rats were euthanized with sodium pentobarbital overdose (150 mg/kg i.p.). All of the aforementioned rats were assessed for behavioral scores as described subsequently to determine neurological impairment, then half of the brain samples were collected subsequent to being perfused with PBS and fixed at room temperature for one day in 4% paraformaldehyde for H&E staining, immunohistochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining and BBB injury assessment. The other half of the brain samples were stored in liquid nitrogen for qPcR and western blot assays as described subsequently.
In the second part of the experiments, rats were randomly divided into the following five groups (n=6): The sham; SAH; SAH+Nc (SAH + transfection reagent); SAH+BI-1 overexpression (SAH+BI-1 over); and SAH+BI-1 shRNA groups. The BI-1/pcdH overexpression and BI-1/pLKO.1 shRNA plasmid were transfected with Entranster-in vivo dNA transfection reagent (Engreen Biosystem NZ, Ltd., Auckland, New Zealand) by using a ventricular puncture stereotactic apparatus and a microinjection pump. Briefly, 5 µg plasmids were dissolved in 5 µl sterile water, and 10 µl Entranster-in vivo DNA transfection reagent was added to 5 µl plasmid. Then, the mixture was incubated for 15 min at room temperature. Finally, the aforementioned mixture was injected by using a microinjection pump under a ventricular puncture stereotactic apparatus. The SAH model was constructed 24 h after this process. All of the rats were assessed for behavioral scores as described subsequently to determine neurological impairment, and all samples were collected as aforementioned.
Neurological impairment. The neurological deficits were scored blindly to assess behavioral performance following ischemic injury according to the method outlined by Sugawara et al (29) . This method was divided into six parts, namely: Autonomic activity; limb movement; forelimb extension; self-climbing cage; axillary touch response; and nasal hair touch response. Each category was scored out of 3 points, with a total of 18 points available. The evaluation process lasted ~5 min.
Brain edema. Brain edema was examined by using the wet-dry method: The rats were euthanized with sodium pentobarbital (150 mg/kg i.p.). The whole brain tissues were collected and weighed immediately, the measurement of which was considered the wet weight. Then, brain tissues were placed into the oven at 100˚C for 72 h and then weighed, and this was considered dry weight. The brain edema index (%) was calculated as follows: [(Wet weight-dry weight)/wet weight] x100%.
Hematoxylin and eosin (H&E) staining. Fixed brain tissues were dehydrated with various concentrations of xylene and ethanol (50% ethanol for 4 h, 75% ethanol for 4 h, 85% ethanol for 3 h, 95% ethanol for 2 h, 100% ethanol for 1 h, 100% ethanol for 1 h, 1:1 ethanol-xylene for 1 h, xylene for 1 h and xylene for 30 min at room temperature), embedded in paraffin, and sliced into 4 µm section. Pathological changes were detected by H&E staining, hematoxylin staining for 5-10 min and eosin staining for 1 min at room temperature (Beijing Solarbio Science & Technology co., Ltd., Beijing, china). The hippocampus in brain sections was observed under a light microscope and the magnification was x200 (Olympus Corporation, Tokyo, Japan).
Immunohistochemical analysis. Sections (thickness, 4 µm)
were dewaxed with various concentrations of xylene and ethanol (xylene for 10 min, xylene for 5 min, 100% ethanol for 5 min, 95% ethanol for 2 min, 80% ethanol for 2 min and 70% ethanol for 2 min). Sections were incubated with biotin-labeled rabbit anti-rat IgG (dilution 1:1,000; cat. no. RS030826; ImmunoWay Biotechnology company, Plano, TX, USA) at 4˚C overnight. Subsequent to being washed three times with PBS, sections were incubated with horseradish peroxidase (HRP)-conjugated streptomycin secondary antibody (1:200; cat. no. SE068; Beijing Solarbio Science & Technology co., Ltd.) for 2 h at room temperature. Nuclei were stained with 0.5% hematoxylin for 5 min at room temperature. Brown staining indicated positive cells and blue staining indicated nuclei. The brain sections were observed under a light microscope and the magnification was x200 (Olympus Corporation).
TdT-mediated dUTP nick-end labeling (TUNEL) staining.
A colorimetric TUNEL apoptosis assay kit was purchased from Beyotime Institute of Biotechnology to detect apoptosis in hippocampal neurons in the brain tissues. Experiments were performed according to the manufacturer's protocol. Briefly, samples were fixed at room temperature for one day in 4% paraformaldehyde, slides were dewaxed with various concentrations of xylene and ethanol (xylene for 10 min, xylene for 5 min, 100% ethanol for 5 min, 95% ethanol for 2 min, 80% ethanol for 2 min and 70% ethanol for 2 min at room temperature), and incubated with 20 µg/ml proteinase K (DNase free) for 30 min at 37˚C. Subsequent to being washed three times with PBS, slides were incubated with 3% H 2 O 2 for 20 min at room temperature to inactivate the endogenous peroxidase. Following washing, slides were incubated with 50 µl TUNEL reaction mixture for 60 min at 37˚C in the dark, and then washed. Then, the slides were incubated with 200 µl stop solution for 10 min at room temperature. Following this, the slides were incubated with 50 µl streptavidin-HRP working solution for 30 min at room temperature. Subsequent to washing, the slides were incubated with 400 µl dAB solution for 5-30 min at room temperature. Apoptosis-positive cells stained brown, and cell nuclei were stained with hematoxylin for 5 min at room temperature., which appeared blue. The degree of apoptosis was visualized via fluorescence light microscopy and the magnification was x200 (Olympus Corporation). Each slice was randomly selected over three fields.
qPCR. Total RNA from the brain tissues was isolated using TRIzol ® (Takara Biotechnology co., Ltd., dalian, china). A PrimeScript™ 1st strand cdNA synthesis kit (Takara Biotechnology co., Ltd.) was used to synthesize cdNA. The reaction mixture included the following: 1 µl 50 µM oligo dT primers; 1 µl dNTP mixture; and 1 µg template RNA. Then, RNase-free dH 2 O was added to make up 10 µl total volume, followed by incubation at 65˚C for 5 min, and then cooling on ice. Secondly, 10 µl reaction mixture, 4 µl 5X PrimeScript buffer, 0.5 µl RNase inhibitor, and 1 µl PrimeScript RTase were combined, then RNase-free dH 2 O was added to make up a total reaction volume of 20 µl, followed by incubation at 30˚C for 5 min, 42˚C for 30 min, and then 95˚C for 5 min. qPcR was performed by using SYBR Fast qPcR Mix (Takara Biotechnology co., Ltd.) with an ABI 7300 PcR system. The reaction protocol including the following: 10 µl SYBR Fast qPcR Mix (2X); 0.8 µl PcR forward primer (10 µM); 0.8 µl PcR reverse primer (10 µM); 0.4 µl ROX reference dye (50X); 1 µl cdNA; and dH 2 O up to 20 µl. The PcR thermocycler conditions were as follows: 95˚C for 30 sec, followed by 40 cycles: Denaturation at 95˚C for 5 sec and annealing at 60˚C for 10 sec. Relative expression was calculated using the 2 -ΔΔcq formula (30) . data were normalized to the β-actin gene. The following primers were used: BI-1 forward, AcG GAc TcT GGA Acc ATG AA; BI-1 reverse, AGc cGc cAc AAA cAT AcA A; GPP78 forward, ccA ccA GGA TGc AGA cAT TG; GPP78 reverse, AGG Gcc Tcc AcT Tcc ATA GA; IRE1 forward, AAG TTT TGG AAG AGc cAG cA; IRE1 reverse, TGT TcT TGc cTc cAA GTG TG; JNK forward, cGG AAc Acc TTG Tcc TGA A; JNK reverse, TcG ccT GAc TGG cTT TAA GT; ASK forward, ATc ccA GAG Tcc ATG TcT Gc; ASK reverse, GcA Acc AcA TAc ccG AGA GT; cHOP forward, AGc AGA GGT cAc AAG cAc cT; cHOP reverse, cTG cTc cTT cTc cTT cAG c.
Western blot analysis. Proteins from the brain tissues were extracted via lysis buffer (Beyotime Institute of Biotechnology). The total protein concentrations were determined using a BcA protein assay kit (Beyotime Institute of Biotechnology). Proteins (30 µg) were separated by 10% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes. Membranes were blocked with 10% skimmed milk in TBST (TBS containing 0.1 % Tween-20) at room temperature for 1.5 h. Following blocking, membranes were incubated with primary antibodies, followed by HRP Goat Anti-Rabbit IgG (H+L) secondary antibodies (dilution 1:2,000; cat. no. AS014; ABclonal Biotech co., Ltd., Wuhan, china) or HRP Goat Anti-Mouse IgG (H+L) secondary antibodies (dilution 1:2,000; cat. no. AS003; ABclonal Biotech co., Ltd.). The following primary antibodies were used: BI-1 antibody (dilution 1:1,000; cat. no. sc-73483; Santa cruz Biotechnology, Inc., dallas, TX, USA), cHOP antibody (dilution 1:1,000; cat. no. A11346, ABclonal, Biotech), GPR78 antibody (dilution 1:1,000; cat. no. A12364; ABclonal Biotech), IRE1α antibody (dilution 1:1,000; cat. no. 37073; Abcam, cambridge, MA, USA), JNK antibody (dilution 1:1,000; cat. no. A2462; ABclonal Biotech), ASK1 antibody (dilution 1:1,000; cat. no. A6274; ABclonal Biotech), caspase 3 (dilution 1:1,000; cat. no. A11319; ABclonal Biotech), caspase 9 (dilution 1:1,000; cat. no. A7523; ABclonal Biotech) and albumin (dilution 1:500; cat. no. A0353; ABclonal Biotech). Subsequently, the bands were visualized by enhanced chemiluminescence (Advansta, Inc. Menlo Park, cA, USA). The densities of the bands were detected using Image J 2x software (National Institutes of Health, Bethesda, Md, USA), and normalized to β-actin.
Statistical analysis. data are expressed as the mean ± standard deviation. The GraphPad Prism software version 5.0a (GraphPad Software, Inc., La Jolla, cA, USA) was used for statistical analysis. One-way analysis of variance, followed by Tukey's Multiple comparison post hoc test, was used to analyze the differences among the groups. P<0.05 was considered to indicate a statistically significant difference.
Results
Neurological scoring and brain water content. As indicated in Fig. 1A , the SAH model groups demonstrated markedly decreased neurological scores compared with the control and sham groups, and the SAH 24 h group exhibited lower neurological scores compared with all the other groups. In Fig. 1B , it was indicated that the brain water indexes in the SAH model groups were increased compared with those of the control and sham groups. In addition, the SAH 24 h group exhibited the highest brain water index compared with the SAH 48 h and 72 h groups. Therefore, it was concluded that the SAH 24 h model was the most effective.
Pathological analysis of hippocampal neurons. In the control and sham groups, the hippocampal neurons were aligned in a well-ordered manner, with normal morphology and without heteromorphic neurons (Fig. 2) . compared with the sham group, the SAH 24, 48 or 72 h groups exhibited an increased number of heteromorphic neurons in the hippocampus (Fig. 2) . Additionally, the SAH 24 h group had the highest number of heteromorphic neurons compared with the other groups (Fig. 2) . This result indicated that SAH may induce brain injury. According to the aforementioned results, the optimum SAH time (24 h) was selected for subsequent SAH model experiments.
Expression levels of BI-1 in brain tissues following SAH. To investigate the expression of BI-1 in brain tissues following SAH, qPcR and western blot analysis were used to detect the changes in BI-1 in all groups. It was identified that the levels of BI-1 in the brain tissues were significantly suppressed following SAH compared with those of the sham group, and the level of BI-1 was the lowest at 24 h after SAH (Fig. 3) . These results indicated that BI-1 expression was associated with early brain injury following SAH, and this expression may have an important role in brain injury repair.
Effects of BI-1 shRNA and BI-1 overexpression on neurological scores, brain water index, H&E staining and BBB permeability.
The BI-1 levels in negative control (Nc), pcdH, BI-1/pcdH, BI-1/pLKO.1 shRNA and scrambled shRNA/pLKO.1 cells were examined prior to use in the animal model. As demonstrated in Fig. 4A -c, the mRNA and protein levels of BI-1 were markedly increased in the BI-1/pcdH group compared with that in other groups, and decreased in BI-1/pLKO.1 shRNA group compared with that in other groups. Furthermore, there were no differences detected among the Nc, pcdH and scramble shRNA/pLKO.1 groups (Fig. 4A-c) . As no differences were detected among the Nc, pcdH and scrambled shRNA/pLKO.1 groups, only a single control group (the Nc group) was used in the subsequent animal experiments.
The neurological scores were significantly decreased in the SAH+BI-1 shRNA group and increased in the SAH+BI-1 over group compared with those in the SAH group (Fig. 4d) . The brain water indexes were significantly increased in the SAH+BI-1 shRNA group and decreased in the SAH+BI-1 over group compared with those in the SAH group (Fig. 4E) .
Similarly, the expression levels of albumin in the SAH group and the SAH+BI-1 shRNA group were increased compared with that in the sham group and were highest in the SAH+BI-1 shRNA group. In addition, the levels of albumin in the SAH+BI-1 over group were decreased compared with those in the SAH group but were increased compared with those in the sham group (Fig. 5A ). To additionally detect BBB permeability, the levels of IgG in the brain tissues were also assessed by IHC assays. In Fig. 5B , it was identified that the IgG levels in the brains were increased following SAH compared with those in the sham group and highest in the SAH+BI-1 shRNA group. BI-1 overexpression significantly suppressed the IgG induced by SAH in the SAH+BI-1 over group compared with the SAH group (Fig. 5B) . The quantification of IgG-positive cells was also analyzed (Fig. 5c ). The results suggested that BI-1 inhibited the BBB permeability induced by brain injury following SAH.
As indicated in Fig. 6 , the SAH group and the SAH+Nc group contained increased numbers of heteromorphic neurons compared with the sham group, and the number of heteromorphic neurons in the SAH+BI-1 shRNA group was increased compared with that in the SAH and SAN+Nc groups. However, the SAH+BI-1 over group exhibited a decreased number of heteromorphic neurons compared with the SAH+BI-1 shRNA group, but this number was increased compared with that in the sham group. These results implied that BI-1 repaired and rescued brain injury following SAH.
Effects of BI-1 shRNA and BI-1 overexpression on ER stress-associated apoptosis.
To demonstrate the effects of BI-1 on apoptosis, TUNEL assays of brain tissues were performed. The number of apoptosis-positive cells was markedly increased in the SAH group and the SAH+Nc group compared with the sham group, and BI-1 shRNA significantly attenuated apoptosis in the SAH+ BI-1 shRNA group compared with the SAH group (Fig. 7A ). However, BI-1 overexpression significantly rescued the high levels of apoptosis in the SAH+ BI-1 over group compared with the SAH group (Fig. 7A ). This result suggested that BI-1 may inhibit the apoptosis induced by SAH. The percentage of TUNEL-positive cells was also analyzed (Fig. 7B) . The expression levels of apoptosis-associated proteins caspase 3 and caspase 9 in these groups via western blot analysis. These results were consistent with TUNEL assays (Fig. 7c and d) .
To additionally investigate the mechanism of apoptosis, the expression levels of ER stress-associated genes (GPR78, cHOP, IRE1, JNK and ASK1) were analyzed using qPcR and western blot analysis. As indicated in Fig. 8 , the levels of GPR78, cHOP, IRE1, JNK and ASK1 were increased in the SAH group compared with those in the sham group, and were also increased in the SAH+BI-1 shRNA group compared with those in the SAH group. The expression levels of all genes were decreased in SAH+BI-1 over group compared with those in the SAH group; however, these levels were increased compared with those in the sham group. No difference between the SAH and SAH +Nc groups was observed. These results indicated that BI-1 may inhibit ER stress-associated apoptosis induced by SAH.
Discussion
The present study examined the neuroprotective and anti-apoptotic effects of BI-1 on EBI following SAH in a rat model. It was identified that BI-1 overexpression markedly increased neurological scores, and decreased the brain water index and the number of heteromorphic neurons in the hippocampal area. Furthermore, BI-1 overexpression also restored BBB function and suppressed the ER stress-mediated apoptosis induced by EBI following SAH in the hippocampal area. By contrast, BI-1 shRNA demonstrated the opposite results.
EBI is regarded as an important and potential implementation target of treatment for SAH due to pathophysiological variables occurring during the EBI period, defined as the first 72 h after SAH (2,6). During the EBI period, a number of physiological disruptions occur, including increased IcP, Figure 3 . Expression levels of BI-1 at different time points during early brain injury following SAH. (A) The mRNA levels of BI-1 at 24, 48 and 72 h after SAH were detected by quantitative polymerase chain reaction assay. (B) The protein levels of BI-1 at 24, 48 and 72 h after SAH were detected by western blot analysis. (c) Protein levels were normalized to that of β-actin. All experiments were repeated at least three times. All data are presented as the mean ± standard deviation. * P<0.05 and *** P<0.001 vs. con group. BI-1, B-cell lymphoma 2-associated X protein-inhibitor-1; con, control; SAH, subarachnoid hemorrhage. decreased CBF, brain edema, BBB disruption, inflammation and oxidative cascades that all ultimately lead to cell death (4) . Neurological scores are associated with the pathophysiological aspects of SAH. The present study first evaluated the neurological scores of rats following SAH, and the lowest scores were observed at 24 h after SAH compared with those at 48 and 72 h. Brain edema was assessed by brain water content. The highest brain water index was measured at 24 h after SAH compared with those of the other groups. The H&E staining results were also consistent with these data. The levels of BI-1 in the brain tissues at 24, 48 and 72 h after SAH were also determined. The levels of BI-1 at 24 h were decreased compared with those of the other groups. This result indicated that BI-1 exhibited a positive effect on brain tissues following SAH and alleviated EBI. Therefore, 24 h after SAH was selected the optimal time period for subsequent experiments in the present study.
BI-1 is an evolutionarily conserved cytoprotective protein. To additionally investigate the effect of BI-1 on EBI following SAH, SAH models were treated with BI-1 overexpression and shRNA plasmids. Neurological scores were significantly increased and the brain water index was decreased in the SAH+BI-1 over group compared with those in the SAH group.
However, BI-1 shRNA significantly decreased the neurological scores and increased the brain water index compared with those in the SAH group. Brain edema has been considered to have a direct effect on BBB disruption (2) . The aforementioned results suggested that BI-1 has an important function in limiting EBI following SAH.
In addition to brain water content, the levels of albumin and IgG in brain tissues are also hallmarks of BBB integrity (31, 32) . Under normal circumstances, the albumin serum protein IgG cannot completely permeate the BBB. However, following cerebral injury, albumin and IgG may permeate the brain tissue, indicating that the BBB integrity has been damaged and permeability is increased (33, 34) . Therefore, the expression of albumin and IgG extravasation in brain tissue may be detected to reflect the injury and permeability of the BBB. The present study detected albumin levels using western blot analysis, and detected IgG levels using immunohistochemical assays. The levels of albumin were markedly increased in the SAH group compared with those in the sham group. In addition, the levels of albumin decreased in the SAH+BI-1 over group and increased in the SAH+BI-1 shRNA group compared with those in the SAH group. Using IgG immunohistochemistry, positively-stained neuronal cells in the hippocampal area were EBI following SAH. As indicated in the results of the H&E staining, these data were consistent with the aforementioned results.
Previous studies suggested that EBI is one of the important factors affecting poor prognosis following SAH (35, 36) , and EBI is involved in a number of processes, including apoptosis, oxidative stress and neuroinflammation (7, 37, 38) . It has also been suggested that the apoptosis of neuronal cells is an important factor in EBI following SAH, which may explain the serious outcomes of SAH (39, 40) . In the present study, the effect of BI-1 on apoptosis in EBI following SAH was examined via TUNEL assays. It was identified that the SAH group exhibited more TUNEL-positive neuronal cells in the hippocampal area compared with the sham group. BI-1 significantly inhibited the number of TUNEL-positive neuronal cells in the SAH+BI-1 over group compared with the SAH group, and the opposite results were observed in the SAH+BI-shRNA group.
ER stress is associated with various human neurodegenerative diseases (41) . downstream factors of ER stress may induce neuronal apoptosis following SAH (42) . However, certain previous studies have suggested that ER stress is induced in cerebral ischemia and that ER stress-mediated reactions may inhibit neuronal apoptosis (43) . ER stress appears to serve dual roles in neuronal apoptosis (44, 45) . Therefore, the present study aimed to investigate the association between ER stress and apoptosis in EBI following SAH. The levels of ER stress signaling genes, namely GPR78, cHOP, IRE-1, JNK and ASK1, which are associated with ER stress, were examined via qPcR and western blot analysis. The results suggested that ER stress-mediated apoptosis was markedly induced in the SAH group compared with the sham groups. In addition, BI-1 inhibited the ER stress-mediated apoptosis induced by EBI following SAH.
In conclusion, the results from the present study demonstrate that BI-1 exerts a neuroprotective effect on EBI following SAH by suppressing apoptosis. The overexpression of BI-1 alleviated EBI following SAH and apoptosis, suggesting that BI-1 may represent a potential therapeutic strategy for EBI following SAH. It was also demonstrated that ER stress mediated-apoptosis served an important role in SAH treatment, and BI-1 may inhibit EBI following SAH by suppressing an apoptotic pathway associated with ER stress. Mitochondria-derived Figure 8 . Potential mechanism of the effects of BI-1 on apoptosis induced by early brain injury following SAH. (A) The mRNA levels of GPR78, cHOP, IRE-1, JNK and ASK1 were detected by quantitative polymerase chain reaction assays. (B) The protein levels of GPR78, cHOP, IRE-1, JNK and ASK1 were detected by western blot analysis. (c) Protein levels were normalized to that of β-actin. All experiments were repeated at least three times. All data are presented as the mean ± standard deviation. * P<0.05, ** P<0.01 and *** P<0.001 vs. the control group. # P<0.05, ## P<0.01 and ### P<0.001 vs. the SAH group. BI-1, B-cell lymphoma 2-associated X protein-inhibitor-1; shRNA, short hairpin RNA; SAH, subarachnoid hemorrhage; SAH+BI-1 over, SAH + BI-1 overexpression; Nc, negative control; cHOP, c/EBP homologous protein; GRP78, Glucose regulated protein, 78 kda; IRE1, Serine/threonine-protein kinase/endoribonuclease IRE1; ASK1, apoptotic signaling kinase-1; JNK, c-Jun N terminal kinases. stresses are also associated with neuropathological and neurodegenerative diseases (46) . Mitochondria are central organelles in neuronal physiology integrating several crucial functions, including energy metabolism, cell respiration and ca 2+ homeostasis, all of which have been revealed to be dysregulated in Alzheimer's disease and other neurodegenerative disorders, such as Parkinson's disease (47, 48) . Several studies have reported that the mitochondrial pathway is closely associated with EBI following SAH (49, 50) . Therefore, the association among BI-1, SAH and mitochondria-derived stresses will be addressed in future studies.
